Literature DB >> 18775481

Modulation of expression of RA-regulated genes by the oncoprotein v-erbA.

Tereza Ventura-Holman1, Abulkhair Mamoon, Jose S Subauste.   

Abstract

Retinoic acid (RA) modulates the expression of genes involved in embryogenesis, development and differentiation processes in vertebrates. The v-erbA oncogene is known to exert a dominant-negative effect on the expression of RA-responsive genes. v-erbA belongs to a superfamily of transcription factors called nuclear receptors, which includes the retinoic acid receptors (RARs) responsible for mediating the effects of retinoic acid. While RA inhibits cell proliferation and promotes cell differentiation and apoptosis in a variety of tissues, v-erbA seems to play a role in oncogenesis, namely in the development of hepatocellular carcinoma (HCC) in a transgenic mouse model. In order to study the effect of v-erbA on RA-responsive genes, we used microarray analysis to identify genes differentially expressed in murine hepatocytes in culture (AML12 cells) stably transfected with v-erbA and exposed to RA for 3 h or 24 h. We have identified RA-responsive genes that are affected by v-erbA, as well as genes that are regulated by v-erbA alone. We have found that v-erbA can affect gene expression in the presence of RA and at the level of basal transcription. We have also identified a number of v-erbA-responsive genes that are known to be involved in carcinogenesis and which may play a role in the development of HCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775481     DOI: 10.1016/j.gene.2008.08.006

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Recruitment of the oncoprotein v-ErbA to aggresomes.

Authors:  Cornelius Bondzi; Abigail M Brunner; Michelle R Munyikwa; Crystal D Connor; Alicia N Simmons; Stephanie L Stephens; Patricia A Belt; Vincent R Roggero; Manohara S Mavinakere; Shantá D Hinton; Lizabeth A Allison
Journal:  Mol Cell Endocrinol       Date:  2010-11-12       Impact factor: 4.102

2.  The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma.

Authors:  Tereza Ventura-Holman; Abulkhair Mamoon; Maria C Subauste; Jose S Subauste
Journal:  Mol Biol Rep       Date:  2010-06-23       Impact factor: 2.316

3.  Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas.

Authors:  Meghan D Rosen; Ivan H Chan; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2011-05-26

4.  Retinoid-responsive transcriptional changes in epidermal keratinocytes.

Authors:  Ding-Dar Lee; Olivera Stojadinovic; Agata Krzyzanowska; Constantinos Vouthounis; Miroslav Blumenberg; Marjana Tomic-Canic
Journal:  J Cell Physiol       Date:  2009-08       Impact factor: 6.384

5.  Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation.

Authors:  M Ionta; M C Rosa; R B Almeida; V M Freitas; P Rezende-Teixeira; G M Machado-Santelli
Journal:  Braz J Med Biol Res       Date:  2012-05-24       Impact factor: 2.590

6.  Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire.

Authors:  I H Chan; M L Privalsky
Journal:  Oncogene       Date:  2009-09-14       Impact factor: 9.867

7.  Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue.

Authors:  Patricio Godoy; Agata Widera; Wolfgang Schmidt-Heck; Gisela Campos; Christoph Meyer; Cristina Cadenas; Raymond Reif; Regina Stöber; Seddik Hammad; Larissa Pütter; Kathrin Gianmoena; Rosemarie Marchan; Ahmed Ghallab; Karolina Edlund; Andreas Nüssler; Wolfgang E Thasler; Georg Damm; Daniel Seehofer; Thomas S Weiss; Olaf Dirsch; Uta Dahmen; Rolf Gebhardt; Umesh Chaudhari; Kesavan Meganathan; Agapios Sachinidis; Jens Kelm; Ute Hofmann; René P Zahedi; Reinhard Guthke; Nils Blüthgen; Steven Dooley; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2016-06-23       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.